NCT07504458 2026-04-16
QUATRO-APL
Quetzal Therapeutics
Phase 3 Recruiting
Clinical Trials
16 trialsNCT07296445 2025-12-29
LATITUDE
SDK Therapeutics, Inc.
Phase 3 Not yet recruiting
NCT02688140 2025-02-26
TUD-APOLLO-064
Technische Universität Dresden
Phase 3 Completed
NCT00492856 2023-01-10
S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia
SWOG Cancer Research Network
Phase 3 Completed
NCT00482833 2022-10-12
APL0406
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3 Completed
NCT02899169 2021-09-08
APL16
First Affiliated Hospital Xi'an Jiaotong University
Phase 3 Unknown
NCT04175587 2019-11-29
RIF
Peking University People's Hospital
Phase 3 Unknown
NCT01226303 2017-01-26
Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 3 Unknown
NCT00378365 2014-04-16
Acute Promyelocytic Leukemia 2006 (APL)
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT00454168 2014-01-06
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002658 2013-12-19
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002701 2013-09-20
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00006223 2013-06-24
flt3L in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003934 2013-06-05
Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
National Cancer Institute (NCI)
Phase 3 Completed
NCT00599937 2008-01-24
APL93: Timing of CxT and Role of Maintenance
Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
Phase 3 Completed
NCT00591526 2008-01-14
A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)
Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
Phase 3 Completed